Finally, we assessed whether Pak1 and CaMKIIγ expression is associated with breast cancer patient outcome by examining the expression level of both genes at mRNA level from a set of data of a breast cancer METABRIC study obtained from the Cancer Genome Atlas website. This evidence concerns the gene PAK1 and breast carcinoma.